The Benefit of Cardiac Resynchronization Therapy Is Not Hindered by the Number of Comorbidities-Reference-Cited by-同舟云学术

The Benefit of Cardiac Resynchronization Therapy Is Not Hindered by the Number of Comorbidities

Published:2017-10 Issue:16 Volume:70 Page:2096-2097
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Barra Sérgio,Providência Rui,Agarwal Sharad,Marijon Eloi,Boveda Serge

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference3 articles.

1. Multiple comorbidities and response to cardiac resynchronization therapy: MADIT-CRT long-term follow-up;Zeitler;J Am Coll Cardiol,2017

2. Primary prevention implantable cardioverter defibrillator (ICD) therapy in women—data from a multicenter French registry;Providência;J Am Heart Assoc,2016

3. Electrical storms in patients with implantable cardioverter-defibrillators for primary prevention;Escande;J Am Coll Cardiol,2016

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comorbidities and clinical response to cardiac resynchronization therapy: patient‐level meta‐analysis from eight clinical trials;European Journal of Heart Failure;2023-09-15

2. Second European Cardiac Resynchronisation Therapy Survey (Crt Survey Ii): Latvian Data Compared to Europe;Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences.;2020-12-01

3. Implantable cardioverter defibrillator therapy for primary prevention of sudden cardiac death in the real world: Main findings from the French multicentre DAI-PP programme (pilot phase);Archives of Cardiovascular Diseases;2019-08